6275-99-6Relevant articles and documents
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PLATINUM-DRUG RESISTANT CANCER
-
Paragraph 0343; 0354-0355, (2018/07/31)
VAR2CSA-drug conjugates for targeting and inhibiting the growth of cancer cells that have developed resistance to a platinum drug and the use of the conjugates in the treatment of platinum drug-resistant cancers. VAR2CSA-drug conjugates (VDCs) comprise a
SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES
-
Page/Page column 111; 122; 123; 140, (2015/07/15)
Sulfonamide-containing linkage systems for release of payload compounds from an attached targeting moiety in drug conjugates. The conjugates have the formula of [(P)-(L)]m-(T), wherein (P) is a payload compound, (L) is a linker, (T) is a targeting moiety and m is an integer from 1- to 10. Also provided are pharmaceutical compositions comprising such conjugates and there use in treating cancer.
Condensation reactions of trifluoronitrosomethane CF3NO with sulfanilamide H2NC6H4SO2NH2 - Preparation of CF3NNC6H4SO2NH2, CF3NNC6H4SO2NNCF3, CH3C(O)N(H)C6H4SO2NNCF3
Minkwitz, Rolf,Jakob, Jens,Winter, Andreas
, p. 647 - 654 (2007/10/03)
We report the condensations of trifluoronitrosomethane with sulfanilamide. The new compounds p-trifluoromethylazophenylsulfonamide CF3NNC6H4SO2NH2, p-trifluoromethylazosulfonyltrifluoromethylazobenzole CF3NNC6H4SO2NNCF3 and p-trifluoromethylazosulfonyl-acetanilide CH3C(O)N(H)C6H4SO2NNCF3 were characterized by elemental analysis, IR, Raman, mass, 1H, 19F and 13C NMR spectroscopy. In addition we present our approach to the preparation of p-trifluoromethylazosulfonylaniline H2NC6H4SO2NNCF3 by using protecting groups for the amino group.